These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 34890435)

  • 1. Persister control by leveraging dormancy associated reduction of antibiotic efflux.
    Roy S; Bahar AA; Gu H; Nangia S; Sauer K; Ren D
    PLoS Pathog; 2021 Dec; 17(12):e1010144. PubMed ID: 34890435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophages and Growth Dynamics Confound Experimental Results with Antibiotic-Tolerant Persister Cells.
    Harms A; Fino C; Sørensen MA; Semsey S; Gerdes K
    mBio; 2017 Dec; 8(6):. PubMed ID: 29233898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of persister fractions suggests different mechanisms of formation among environmental isolates of E. coli.
    Hofsteenge N; van Nimwegen E; Silander OK
    BMC Microbiol; 2013 Feb; 13():25. PubMed ID: 23379956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medium chain unsaturated fatty acid ethyl esters inhibit persister formation of Escherichia coli via antitoxin HipB.
    Wang M; Fang K; Hong SMC; Kim I; Jang IS; Hong SH
    Appl Microbiol Biotechnol; 2018 Oct; 102(19):8511-8524. PubMed ID: 30088019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persister Escherichia coli Cells Have a Lower Intracellular pH than Susceptible Cells but Maintain Their pH in Response to Antibiotic Treatment.
    Goode O; Smith A; Zarkan A; Cama J; Invergo BM; Belgami D; Caño-Muñiz S; Metz J; O'Neill P; Jeffries A; Norville IH; David J; Summers D; Pagliara S
    mBio; 2021 Aug; 12(4):e0090921. PubMed ID: 34281389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Integration Host Factor in Escherichia coli Persister Formation.
    Nicolau SE; Lewis K
    mBio; 2022 Feb; 13(1):e0342021. PubMed ID: 34982597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth arrest or drug target inactivity is not sufficient for persister formation in E. coli.
    Xu Y; Cui P; Zhang Y; Zhang W
    Discov Med; 2020; 29(157):103-112. PubMed ID: 33002406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli.
    Hansen S; Lewis K; Vulić M
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2718-26. PubMed ID: 18519731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced Efflux Activity Facilitates Drug Tolerance in Dormant Bacterial Cells.
    Pu Y; Zhao Z; Li Y; Zou J; Ma Q; Zhao Y; Ke Y; Zhu Y; Chen H; Baker MAB; Ge H; Sun Y; Xie XS; Bai F
    Mol Cell; 2016 Apr; 62(2):284-294. PubMed ID: 27105118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of oxidative stress in persister tolerance.
    Wu Y; Vulić M; Keren I; Lewis K
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4922-6. PubMed ID: 22777047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Genetic Determinant of Persister Cell Formation in Bacterial Pathogens.
    Cameron DR; Shan Y; Zalis EA; Isabella V; Lewis K
    J Bacteriol; 2018 Sep; 200(17):. PubMed ID: 29941425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Throughput Screening of a Promoter Library Reveals New Persister Mechanisms in Escherichia Coli.
    Mohiuddin SG; Massahi A; Orman MA
    Microbiol Spectr; 2022 Feb; 10(1):e0225321. PubMed ID: 35196813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reassessing the Role of Type II Toxin-Antitoxin Systems in Formation of Escherichia coli Type II Persister Cells.
    Goormaghtigh F; Fraikin N; Putrinš M; Hallaert T; Hauryliuk V; Garcia-Pino A; Sjödin A; Kasvandik S; Udekwu K; Tenson T; Kaldalu N; Van Melderen L
    mBio; 2018 Jun; 9(3):. PubMed ID: 29895634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The frequency of persisters in Escherichia coli reflects the kinetics of awakening from dormancy.
    Jõers A; Kaldalu N; Tenson T
    J Bacteriol; 2010 Jul; 192(13):3379-84. PubMed ID: 20435730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fatty acid signaling molecule cis-2-decenoic acid increases metabolic activity and reverts persister cells to an antimicrobial-susceptible state.
    Marques CN; Morozov A; Planzos P; Zelaya HM
    Appl Environ Microbiol; 2014 Nov; 80(22):6976-91. PubMed ID: 25192989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single cell observations show persister cells wake based on ribosome content.
    Kim JS; Yamasaki R; Song S; Zhang W; Wood TK
    Environ Microbiol; 2018 Jun; 20(6):2085-2098. PubMed ID: 29528544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Putrescine controls the formation of Escherichia coli persister cells tolerant to aminoglycoside netilmicin.
    Tkachenko AG; Kashevarova NM; Karavaeva EA; Shumkov MS
    FEMS Microbiol Lett; 2014 Dec; 361(1):25-33. PubMed ID: 25283595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persister cells: molecular mechanisms related to antibiotic tolerance.
    Lewis K
    Handb Exp Pharmacol; 2012; (211):121-33. PubMed ID: 23090599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viable but Nonculturable and Persister Cells Coexist Stochastically and Are Induced by Human Serum.
    Ayrapetyan M; Williams TC; Baxter R; Oliver JD
    Infect Immun; 2015 Nov; 83(11):4194-203. PubMed ID: 26283335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication of Pseudomonas aeruginosa cells by cathodic electrochemical currents delivered with graphite electrodes.
    Niepa THR; Wang H; Gilbert JL; Ren D
    Acta Biomater; 2017 Mar; 50():344-352. PubMed ID: 28049020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.